ruthenium has been researched along with adamantane in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 11 (68.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belliston-Bittner, W; Dunn, AR; Getzoff, ED; Gray, HB; Stuehr, DJ; Winkler, JR | 1 |
| Bergamo, A; Brescacin, L; Cocchietto, M; Delfino, R; Dyson, PJ; Geldbach, TJ; Laurenczy, G; Sava, G; Scolaro, C | 1 |
| De Cola, L; Faiz, JA; Pikramenou, Z; Silva, MJ; Williams, RM | 1 |
| Gossens, C; Rothlisberger, U; Tavernelli, I | 1 |
| González, B; Havel, J; Lorenzo, P; Peña-Méndez, EM; Romerosa, A | 1 |
| Eads, K; Enow, RA; Frost, BJ; Krogstad, DA; Lee, WC; Sears, JM | 1 |
| Bergamini, P; Ferretti, V; Fogagnolo, M; Marchi, A; Marvelli, L; Sforza, F | 1 |
| Plavec, J; Seršen, S; Šket, P; Turel, I | 1 |
| Alessio, E; Arcangeli, A; Balducci, G; Battistin, F; Messori, L; Pillozzi, S; Scaletti, F | 1 |
| Badillo Patzmay, GV; Kwiecień, A; Lupidi, G; Nabissi, M; Pettinari, C; Pettinari, R; Santoni, G; Smoleński, P; Wołoszyn, A | 1 |
| Chyba, J; Marek, R; Munzarová, P; Novák, M; Novotný, J | 1 |
| Chen, Y; Cheng, N; Li, JJ; Liu, Y; Yu, J | 1 |
| Nordlander, E; Quintero, MAS; Smith, GS; Stringer, T; Wiesner, L | 1 |
| Fadare, OA; Olasunkanmi, LO; Tabrizi, L | 1 |
| Chen, Y; Fu, HG; Liu, Y; Yu, Q | 1 |
| Burmeister, H; Kladnik, J; Kljun, J; Ott, I; Romero-Canelón, I; Turel, I | 1 |
16 other study(ies) available for ruthenium and adamantane
| Article | Year |
|---|---|
Luminescent ruthenium(II)- and rhenium(I)-diimine wires bind nitric oxide synthase.
Topics: Adamantane; Energy Transfer; Hydrophobic and Hydrophilic Interactions; Imidazoles; Imines; Kinetics; Luminescent Agents; Models, Molecular; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Pyridines; Rhenium; Ruthenium; Spectrophotometry, Ultraviolet | 2005 |
In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes.
Topics: Adamantane; Animals; Antineoplastic Agents; Benzene Derivatives; Buffers; Cell Line, Tumor; DNA; Female; Humans; Hydrolysis; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred CBA; Organometallic Compounds; Organophosphorus Compounds; Ruthenium; Sodium Chloride; Solutions; Structure-Activity Relationship; Tissue Distribution; Xenograft Model Antitumor Assays | 2005 |
A unidirectional energy transfer cascade process in a ruthenium junction self-assembled by alpha- and beta-cyclodextrins.
Topics: Adamantane; alpha-Cyclodextrins; beta-Cyclodextrins; Organometallic Compounds; Photochemistry; Pyridines; Ruthenium; Thermodynamics | 2006 |
DNA structural distortions induced by ruthenium-arene anticancer compounds.
Topics: Adamantane; Antineoplastic Agents; Binding Sites; Calixarenes; Computer Simulation; DNA; Ethylenediamines; Guanine; Models, Chemical; Models, Molecular; Molecular Conformation; Organometallic Compounds; Organophosphorus Compounds; Ruthenium; Stereoisomerism; Water | 2008 |
Mass spectrometry and UV-VIS spectrophotometry of ruthenium(II) [RuClCp(mPTA)2](OSO2CF3)2 complex in solution.
Topics: Adamantane; Drug Stability; Organometallic Compounds; Ruthenium; Solubility; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spectrophotometry, Ultraviolet | 2009 |
Hemilabile β-aminophosphine ligands derived from 1,3,5-triaza-7-phosphaadamantane: application in aqueous ruthenium catalyzed nitrile hydration.
Topics: Adamantane; Catalysis; Ligands; Models, Molecular; Molecular Structure; Nitriles; Organometallic Compounds; Organophosphorus Compounds; Phosphines; Ruthenium; Water | 2013 |
Acetylcholine-like and trimethylglycine-like PTA (1,3,5-triaza-7-phosphaadamantane) derivatives for the development of innovative Ru- and Pt-based therapeutic agents.
Topics: Adamantane; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; K562 Cells; Models, Molecular; Molecular Structure; Organometallic Compounds; Organophosphorus Compounds; Platinum; Ruthenium; Structure-Activity Relationship | 2014 |
Interactions of two cytotoxic organoruthenium(II) complexes with G-quadruplex.
Topics: Adamantane; Antineoplastic Agents; Binding Sites; Coordination Complexes; Crystallography, X-Ray; Cymenes; Deuterium; G-Quadruplexes; Magnetic Resonance Spectroscopy; Molecular Conformation; Monoterpenes; Nucleic Acid Denaturation; Organometallic Compounds; Organophosphorus Compounds; Ruthenium; Ultraviolet Rays | 2016 |
Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties.
Topics: Adamantane; Antineoplastic Agents; Bromides; Cell Line, Tumor; Cell Survival; Chlorides; Coordination Complexes; Cytochromes c; Filaggrin Proteins; HCT116 Cells; Humans; Hydrogen-Ion Concentration; Imidazoles; Indazoles; Inhibitory Concentration 50; Ligands; Oligonucleotides; Organometallic Compounds; Organophosphorus Compounds; Protons; Ribonuclease, Pancreatic; Ruthenium; Solubility; Structure-Activity Relationship; Water | 2016 |
Ru(ii)-(PTA) and -mPTA complexes with N
Topics: 2,2'-Dipyridyl; Adamantane; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coordination Complexes; Crystallography, X-Ray; Humans; Multiple Myeloma; Nitrogen; Organophosphorus Compounds; Phenanthrolines; Ruthenium | 2017 |
Through-Space Paramagnetic NMR Effects in Host-Guest Complexes: Potential Ruthenium(III) Metallodrugs with Macrocyclic Carriers.
Topics: Adamantane; Anisotropy; Antineoplastic Agents; Bridged-Ring Compounds; Carbon-13 Magnetic Resonance Spectroscopy; Coordination Complexes; Cyclodextrins; Drug Carriers; Imidazoles; Proton Magnetic Resonance Spectroscopy; Pyridines; Quantum Theory; Ruthenium; Spectrometry, Mass, Electrospray Ionization; X-Ray Diffraction | 2018 |
Enhanced DNA Binding and Photocleavage Abilities of β-Cyclodextrin Appended Ru(II) Complex through Supramolecular Strategy.
Topics: A549 Cells; Adamantane; Anthracenes; beta-Cyclodextrins; Coordination Complexes; DNA; DNA Cleavage; Humans; Light; Photochemical Processes; Photosensitizing Agents; Ruthenium | 2018 |
Evaluation of PTA-derived ruthenium(II) and iridium(III) quinoline complexes against chloroquine-sensitive and resistant strains of the Plasmodium falciparum malaria parasite.
Topics: Adamantane; Animals; Antimalarials; Chloroquine; Coordination Complexes; Drug Resistance; Iridium; Organophosphorus Compounds; Plasmodium falciparum; Quinolines; Ruthenium | 2019 |
Experimental and theoretical investigations of cyclometalated ruthenium(ii) complex containing CCC-pincer and anti-inflammatory drugs as ligands: synthesis, characterization, inhibition of cyclooxygenase and in vitro cytotoxicity activities in various can
Topics: Adamantane; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Coordination Complexes; Cyclooxygenase Inhibitors; Drug Stability; HEK293 Cells; Humans; Ibuprofen; Ligands; MCF-7 Cells; Molecular Docking Simulation; Molecular Structure; Naproxen; Organophosphorus Compounds; Reactive Oxygen Species; Ruthenium | 2019 |
A tumor-targeting Ru/polysaccharide/protein supramolecular assembly with high photodynamic therapy ability.
Topics: A549 Cells; Adamantane; beta-Cyclodextrins; Cell Line; Coordination Complexes; Drug Delivery Systems; Humans; Models, Molecular; Neoplasms; Photochemotherapy; Photosensitizing Agents; Ruthenium; Transferrin | 2019 |
Towards Identification of Essential Structural Elements of Organoruthenium(II)-Pyrithionato Complexes for Anticancer Activity.
Topics: Adamantane; Antineoplastic Agents; Apoptosis; Coordination Complexes; Drug Screening Assays, Antitumor; Humans; Organophosphorus Compounds; Pyridines; Ruthenium; Thiones; Wound Healing | 2019 |